UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$288M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$215M |
| 3 |
Tractor Supply
TSCO
|
+$157M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
PayPal
PYPL
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$339M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$244M |
| 3 |
PX
Praxair Inc
PX
|
+$218M |
| 4 |
Meta Platforms (Facebook)
META
|
+$182M |
| 5 |
Adobe
ADBE
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 14.9% |
| 3 | Financials | 14.08% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Primoris Services
PRIM
$4.45B
| $422K | ﹤0.01% |
22,073
| – | – |
|
2027
TherapeuticsMD
TXMD
$24M
| $421K | ﹤0.01% |
2,209
-56
| -2% | -$13.7K |
|
|
ACOR
2028
DELISTED
Acorda Therapeutics
ACOR
| $418K | ﹤0.01% |
224
| – | – |
|
|
SASR
2029
DELISTED
Sandy Spring Bancorp Inc
SASR
| $417K | ﹤0.01% |
13,300
-5,095
| -28% | -$180K |
|
|
EBSB
2030
DELISTED
Meridian Bancorp, Inc.
EBSB
| $417K | ﹤0.01% |
29,093
| – | – |
|
2031
Iovance Biotherapeutics
IOVA
$2.87B
| $416K | ﹤0.01% |
46,985
+10,677
| +29% | +$103K |
|
|
NCI
2032
DELISTED
Navigant Consulting, Inc.
NCI
| $414K | ﹤0.01% |
17,229
+4,331
| +34% | +$99.1K |
|
|
VTLE
2033
DELISTED
Vital Energy
VTLE
| $414K | ﹤0.01% |
5,723
-3,973
| -41% | -$417K |
|
2034
iShares National Muni Bond ETF
MUB
$45.5B
| $414K | ﹤0.01% |
3,793
-783
| -17% | -$84.3K |
|
|
SLCA
2035
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $413K | ﹤0.01% |
40,583
-16,309
| -29% | -$238K |
|
2036
Unisys
UIS
$217M
| $411K | ﹤0.01% |
35,375
+12,376
| +54% | +$195K |
|
2037
GrafTech
EAF
$212M
| $411K | ﹤0.01% |
3,594
+2,540
| +241% | +$388K |
|
2038
Yext
YEXT
$574M
| $411K | ﹤0.01% |
27,681
+1,148
| +4% | +$20.3K |
|
2039
Standard Motor Products
SMP
$911M
| $410K | ﹤0.01% |
8,470
+21
| +0.2% | +$1.04K |
|
2040
MongoDB
MDB
$32.1B
| $410K | ﹤0.01% |
+4,892
| New | +$376K |
|
2041
Vanguard Morningstar Value ETF
VTV
$191B
| $409K | ﹤0.01% |
4,175
-64
| -2% | -$6.73K |
|
2042
Denali Therapeutics
DNLI
$3.97B
| $409K | ﹤0.01% |
19,773
+5,073
| +35% | +$92K |
|
2043
ePlus
PLUS
$2.34B
| $408K | ﹤0.01% |
11,468
| – | – |
|
|
HTBK
2044
DELISTED
Heritage Commerce
HTBK
| $408K | ﹤0.01% |
35,961
+2,010
| +6% | +$27.9K |
|
2045
AMC Entertainment Holdings
AMC
$2.31B
| $407K | ﹤0.01% |
3,311
+2,301
| +228% | +$377K |
|
2046
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.2B
| $406K | ﹤0.01% |
21,331
+7,131
| +50% | +$154K |
|
2047
First Majestic Silver
AG
$9.07B
| $404K | ﹤0.01% |
68,877
+12,400
| +22% | +$68.9K |
|
|
SPPI
2048
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $404K | ﹤0.01% |
46,209
-13,156
| -22% | -$168K |
|
2049
Scansource
SCSC
$1.12B
| $404K | ﹤0.01% |
11,738
-15
| -0.1% | -$565 |
|
2050
Nelnet
NNI
$4.7B
| $403K | ﹤0.01% |
7,702
-3,682
| -32% | -$198K |
|
Similar funds
UBS AM's Q4 2018 Portfolio in Review
As of Q4 2018, UBS AM held 2,899 positions worth $116B, down 14% from $135B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS AM's Q4 2018 filing shows 140 new, 1,359 increased, 845 reduced and 130 closed positions. Its largest new stake was Linde: 1,823,057 shares worth $284M. The largest sale was Aetna Inc, an estimated $339M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2018 buy was Linde: 1,823,057 shares worth $284M.
- UBS AM added most to iShares US Treasury Bond ETF in Q4 2018, an estimated $215M increase.
- UBS AM's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $182M.
- UBS AM fully exited Aetna Inc in Q4 2018, selling an estimated $339M.
- UBS AM's ten largest holdings make up 17% of its $116B portfolio in Q4 2018.
- UBS AM opened 140 new positions and closed 130 in Q4 2018.
- UBS AM's portfolio value fell 14% quarter-over-quarter to $116B.
Based on UBS AM's 13F filing for Q4 2018, filed 13 Feb 2019.